Live Long...Live Well

What if modern medicine is missing half the picture? In Episode 5 of Live Long Live Well Podcast, Steve Loyd sits down with Dr. Joe Pizzorno, a pioneer in integrative and naturopathic medicine, co-founder of Bastyr University, and author of The Toxin Solution. Dr. Pizzorno shares insights from decades of research and clinical experience, including his work analyzing thousands of peer-reviewed studies alongside Galahad Life Sciences to support the development of new approaches to improving mitochondrial function and overall vitality.

Can biotechnology dramatically extend human health and lifespan? In Episode 4 of Live Long Live Well, Steve Loyd, CEO of Galahad Life Sciences, explains the philosophy and guiding principles behind Galahad's approach to longevity science and biotechnology innovation. After leaving a successful career in finance and academia in his mid-50s, Steve dedicated his life to one mission: slowing and ultimately reversing biological aging so humans can live longer, healthier lives—potentially reaching 200 years of vibrant health. To pursue this ambitious goal, Steve developed a new framework for biotechnology discovery built on three core principles designed to challenge the traditional medical model. This episode explores: • Why Steve believes the current healthcare model is inefficient and outdated • The personal health crisis that pushed him into biotechnology • Galahad's three guiding rules for discovery and innovation • Why the principle "First, Do No Harm" must guide biotechnology development • How breakthroughs often occur between disciplines, not within them • Why evolutionary biology offers powerful clues for solving modern health challenges • How new biotech approaches may improve cellular vitality and mitochondrial function Steve also shares how Galahad brings together expertise from multiple fields—including biotechnology, engineering, materials science, and evolutionary biology—to create safer, more effective solutions that improve human healthspan. The mission of Galahad Life Sciences is simple but ambitious: Help humans live longer, healthier, and more vibrant lives. Future episodes will feature conversations with leaders across disciplines, including: • Biotechnology • Medicine • Biology • Nutrition and exercise science • Evolutionary biology • Psychology and behavioral science. All focused on understanding and addressing one of humanity's biggest challenges: Aging.

Is modern healthcare focused on the wrong goal? In Episode 3 of Live Long Live Well, Steve Loyd, CEO of Galahad Life Sciences, explores why today's medical system may be struggling to deliver what people actually want: long, vibrant, healthy lives. While modern medicine has made extraordinary advances in fighting infectious disease and extending life expectancy, Steve argues that the current healthcare model is still largely focused on disease rather than health. Instead of simply reacting to illness, the future of longevity may depend on shifting toward preventative health, personal responsibility, and new technologies like AI-driven personalized medicine. This episode explores: Why Steve believes the current medical model is outdated  How the germ theory of disease shaped modern healthcare Why focusing only on fighting disease may limit true health outcomes The difference between reactive medicine vs preventative health The economic challenges of a healthcare system consuming $5 trillion annually in the U.S. Why individuals must take a more active role in managing their own health Steve also introduces the idea that future healthcare will combine personalized medicine and preventative health strategies to dramatically improve human healthspan. The ultimate mission of Galahad Life Sciences is to slow and reverse biological aging, helping humans reach their full biological potential—possibly living 200 years in vibrant health. We do not offer medical advice.

Is focusing on life expectancy actually misleading us about health and longevity? This episode explores: The difference between lifespan vs healthspan. How gains in life expectancy have slowed across generations. Why modern healthcare sometimes extends life without preserving quality of life. Steve's personal journey into biotechnology after witnessing family health decline. How biotechnology may help humans live 200 years in vibrant health

Can humans live 200 years in vibrant health? In the first episode of Live Long Live Well, Steve Loyd, CEO of Galahad Life Sciences, explores the future of longevity science and the possibility of dramatically extending the human health span. Rather than simply living longer, the mission is to help humans live longer while remaining strong, independent, and mentally sharp. Steve shares the story behind Galahad Life Sciences and how a conversation with scientists from the Gates Foundation sparked an important question: Why would anyone want to live that long? This episode dives into the deeper reasons behind longevity research, including the economic, scientific, and personal motivations driving the mission to slow—and ultimately reverse—biological aging.  Steve also discusses: The difference between lifespan and healthspan Why reversing aging could create $37 trillion in societal value The personal story that led him to leave a successful career and start a biotechnology company How modern biotechnology has already improved his own health trajectory The concept of longevity singularity—when science advances faster than aging progresses   This podcast series will explore ideas from medicine, biology, exercise, nutrition, psychology, physics, and history to help clarify humanity's biggest challenge: Aging